Showing results (231-240 of 345) with videos related to

Sort By:
Pageof 35
European Journal of Endocrinology|April 15, 2004
Differential expression of somatostatin receptor subtypes in human peripheral blood mononuclear cell subsetsElgin G R Lichtenauer-Kaligis, Virgil A S H Dalm, Sigrid P M A Oomen, et al.
Clinical Endocrinology|February 17, 2007
Expression of activin and inhibin subunits, receptors and binding proteins in human pheochromocytomas: a study based on mRNA analysis and immunohistochemistryJ Hofland, F H van Nederveen, M A Timmerman, et al.
The Journal of Clinical Endocrinology and Metabolism|November 22, 2022
Dissecting the In Vitro Efficacy of Octreotide and Cabergoline in GH- and GH/PRL-Secreting Pituitary TumorsFederico Gatto, Richard A Feelders, Peter M van Koetsveld, et al.
The Journal of Endocrinology|November 29, 2022
Peripheral glucocorticoid receptor antagonism by relacorilant with modest HPA axis disinhibitionEva M G Viho, Jan Kroon, Richard A Feelders, et al.
International Journal of Cancer|February 10, 1998
Pre-clinical comparison of [DTPA0] octreotide, [DTPA0,Tyr3] octreotide and [DOTA0,Tyr3] octreotide as carriers for somatostatin receptor-targeted scintigraphy and radionuclide therapyM De Jong, W H Bakker, W A Breeman, et al.
The Journal of Endocrinology|April 9, 1999
Somatostatin receptor subtype expression in cells of the rat immune system during adjuvant arthritisA M ten Bokum, E G Lichtenauer-Kaligis, M J Melief, et al.
Journal of Molecular Endocrinology|January 24, 2015
Whole-exome characterization of pancreatic neuroendocrine tumor cell lines BON-1 and QGP-1Timon Vandamme, Marc Peeters, Fadime Dogan, et al.
The Journal of Clinical Endocrinology and Metabolism|September 1, 1997
Dissociation between the effects of somatostatin (SS) and octapeptide SS-analogs on hormone release in a small subgroup of pituitary- and islet cell tumorsL J Hofland, W W De Herder, H A Visser-Wisselaar, et al.
Endocrine-Related Cancer|July 20, 2018
Hotspot DAXX, PTCH2 and CYFIP2 mutations in pancreatic neuroendocrine neoplasmsT Vandamme, M Beyens, G Boons, et al.
Life Sciences|October 31, 2023
Applying HDACis to increase SSTR2 expression and radiolabeled DOTA-TATE uptake: from cells to miceMaria J Klomp, Lilian van den Brink, Peter M van Koetsveld, et al.
Pageof 35